Cart
sales@molnova.com
INCA-6
CAS No. 3519-82-2
INCA-6( Triptycene-1,4-quinone )
Catalog No. M27468 CAS No. 3519-82-2
INCA-6 is an inhibitor of Nuclear factor of activated T cells (NFAT) and calcineurin-NFAT signaling.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 47 | In Stock |
|
| 5MG | 29 | In Stock |
|
| 10MG | 48 | In Stock |
|
| 25MG | 93 | In Stock |
|
| 100MG | 315 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 686 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameINCA-6
-
NoteResearch use only, not for human use.
-
Brief DescriptionINCA-6 is an inhibitor of Nuclear factor of activated T cells (NFAT) and calcineurin-NFAT signaling.
-
DescriptionINCA-6 is an inhibitor of Nuclear factor of activated T cells (NFAT) and calcineurin-NFAT signaling.(In Vitro):In human retinal microvascular endothelial cells, INCA-6 (1.0, 2.5 μM) significantly decreases VEGF and serum-induced proliferation without affecting baseline proliferation. In 3-Hz cells, INCA-6 (5 μM) prevents transient outward K+ current downregulation. INCA-6 (10 μM) significantly inhibits ATP-induced CXCL2 expression in rat primary microglia and BV-2 cells. INCA-6 (5 μM) protein expression and reduces SERCA2 transcript levels with and without thapsigargin.(In Vivo):INCA-6 (2.5, 5.0, and 25.0 μM; intravitreal) significantly reduces pathologic neovascularization in oxygen-induced retinopathy and decreases the severity of OIR in a dose dependent manner.
-
In VitroINCA-6 (5 μM; for 24-hour) prevents?transient outward K+?current (Ito)?downregulation in 3-Hz cells.Pre-treatment of BV-2 cells with INCA-6 (10 μM) significantly inhibits ATP-induced CXCL2 expression in BV-2 cells. INCA-6 also inhibits ATP-induced CXCL2 expression in rat primary microglia.?INCA-6 (5 μM) reduces SERCA2 transcript levels as well as protein expression, in the absence or in the presence of ?thapsigargin (TG).INCA-6 (1.0 and 2.5 μM; 24 hours?) treatment significantly decreases both VEGF and serum-induced human retinal microvascular endothelial cells (HRMEC) proliferation, but does not affect baseline proliferation. Cell Proliferation Assay Cell Line:Human retinal microvascular endothelial cells Concentration:0.5, 1.0, or 2.5 μM Incubation Time:24 hours Result:Significantly inhibited VEGF-induced proliferation at 1.0 and 2.5 μM concentrations.
-
In VivoINCA-6 (5.0, or 25.0 μM) treatment significantly reduces pathologic neovascularization in oxygen-induced retinopathy (OIR). Animal Model:Rats bearing OIR model Dosage:2.5, 5.0, or 25.0 μM Administration:Intravitreal injection on days 14(0) and 14(3)Result:Decreased the severity of OIR in a dose dependent manner. Significant inhibition was seen at 5.0 and 25.0 μM concentrations.
-
SynonymsTriptycene-1,4-quinone
-
PathwayOthers
-
TargetOther Targets
-
Recptorprostaglandin F2α
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number3519-82-2
-
Formula Weight284.31
-
Molecular FormulaC20H12O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 2.86 mg/mL (10.06 mM)
-
SMILESO=C1C=CC(=O)C2=C1C3C=4C=CC=CC4C2C=5C=CC=CC53
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Baryla M, et al. Prostaglandin F(2α) stimulates adhesion, migration, invasion and proliferation of the human trophoblast cell line HTR-8/SVneo. Placenta. 2019 Feb;77:19-29.
molnova catalog
related products
-
10,12-Tricosadiynoic...
10,12-Tricosadiynoic acid is a highly selective and orally active inhibitor of acyl-CoA oxidase-1 (ACOX1).
-
Quinfamide
Quinfamide is a compound with the potential to treat tropical parasitic infections such as Amoebiasis and Helminthiasis.
-
BRM/BRG1 ATP Inhibit...
BRM/BRG1 ATP Inhibitor-1 is an allosteric dual Brahma homolog (BRM)/SWI/SNF related matrix-associated actin-dependent regulator of chromatin subfamily A member 2 (SMARCA2) and BRG1/SMARCA4 ATPase activity inhibitor (IC50s<0.005 μM).
